RVL Pharmaceuticals plc
RVLP
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.14M
Close$
Share Statistics
| Market cap | $3.14 Million |
|---|---|
| Enterprise Value | $43.18 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.58 |
| Beta | 1.09 |
| Outstanding Shares | 99,370,291 |
Return
| Return on Equity | -418.14% |
|---|---|
| Return on Assets | -79.93% |
| Return on Invested Capital | -253.94% |
Valuation & Multiples
| P/E Ratio | -0.05 |
|---|---|
| PEG | -0.05 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1.17 |
| Enterprise Value to EBIT | -1 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.37 |
| Debt to Equity | 3.63 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About RVL Pharmaceuticals plc
302 employeesOsmotica Pharmaceuticals plc is a fully integrated biopharmaceutical company focused on the development and commercialization of specialty products that target markets with underserved patient populations. The company has a diverse portf...